NCT01147302View on ClinicalTrials.gov

A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 24, 2011

Primary Completion Date

April 19, 2013

Study Completion Date

June 28, 2013

Conditions
Graft Rejection
Interventions
BIOLOGICAL

Placebo

BIOLOGICAL

C1 Esterase Inhibitor (Human)

Trial Locations (5)

Unknown

ViroPharma Investigative Site, Los Angeles

ViroPharma Investigative Site, Baltimore

ViroPharma Investigative Site, Minneapolis

ViroPharma Investigative Site, Cincinnati

ViroPharma Investigative Site, Heidelberg

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY